Latest biopharmaceutical Stories
Selexis to Meet with Biopharmaceutical Companies Interested in Protein Drug Discovery, Mammalian Cell Line Development and Lead Identification for Therapeutic Drug Development and Manufacturing
SANTA ROSA, Calif., June 4, 2014 /PRNewswire/ -- Ruthigen, Inc., (NASDAQ: RTGN), a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics
BREDA, the Netherlands, June 4, 2014 /PRNewswire/ -- SIGNIFICANTLY EXPANDED RELATIONSHIP CREATED ON BACK OF COLLABORATION SUCCESS arGEN-X, a clinical-stage
SAN DIEGO, June 3, 2014 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and
LONDON, May 28, 2014 /PRNewswire/ -- Imperial Innovations Group plc (AIM:IVO, 'Innovations'), the leading technology commercialisation and investment company and S.R.One
CAMBRIDGE, Mass., May 28, 2014 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating
LONDON and TORONTO, May 28, 2014 /PRNewswire/ -- ThioBridge(TM) linker to attach cytotoxic payloads to alpha fetoprotein PolyTherics Limited ("PolyTherics"),
LONDON, May 23, 2014 /PRNewswire/ -- New Company Created to be a Leading Provider of Technologies and Services to Enable Better Biopharmaceuticals
Transposagen Biopharmaceuticals, Inc., based in Lexington, KY, has announced the issuing of Patent No.
MONROVIA, Calif., May 22, 2014 /PRNewswire/ -- Xencor, Inc.
- a slit in a tire to drain away surface water and improve traction.